Predict I-O: Predicción de la Respuesta a la Terapia en Inmuno-Oncología. Desarrollo de un modelo para la sostenibilidad del sistema de salud.

Datos básicos

Protocolo:
GV/2021/144
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2021
Año de finalización:
2022
PI BIOMÉDICA AUTONÓMICO Finan. Competitiva Pública 20.000,00 €

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL
SARAI PALANCA SUELA

Resultados del Ensayo Clínico


A gated material as immunosensor for in-tissue detection of IDH1-R132H mutation in gliomas

Pla, L; (...); Martinez-Manez, R

Article. 10.1016/j.snb.2021.130406. 2021

  • Open Access.

A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain.

Giménez-Campos MS; (...); Ruíz-García V

Article. 10.1016/j.aprim.2021.102144. 2021

  • Open Access.

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

  • Open Access.

Características clínicas del ingreso por enfermedad mental en una Unidad de Hospitalización Psiquiátrica Comarcal. Estudio descriptivo 2008-2018.

Olcina-Rodriguez JF; (...); Gómez-Pajares F

Article. 10.53680/vertex.v33i157.261. 2022


Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Jimenez-Cortegana, C; (...); de la Cruz-Merino, L

Article. 10.1136/jitc-2020-002323. 2021

  • Open Access.

Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13 , 2980.

Pardo-Sanchez, Jose Miguel; (...); Farràs R

Article. 10.3390/cancers13194825. 2021

  • Open Access.

Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia.

Gil, Jose Vicente; (...); Barragan, Eva

Article. 10.3390/ijms24054440. 2023

  • Open Access.

Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rxeng.2021.09.004. 2022

  • Open Access.

From real world data to personalized pharmacotherapy. Where do we stand?

Lopez-Briz, Eduardo, Pablo Ordovas-Baines, Juan

Editorial Material. 10.7399/fh.13048. 2021

  • Open Access.

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

  • Open Access.

Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Lopez-Briz, Eduardo; (...); Carbonell Sanchis, Rafael

Article. 10.1002/14651858.CD008462.pub4. 2022


Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.

Simarro, Javier; (...); Palanca, Sarai

Article. 10.3390/cancers15061705. 2023

  • Open Access.

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1016/j.jinf.2021.01.003. 2021

  • Open Access.

Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation

Pardo-Sanchez, JM; (...); Farras, R

Article. 10.3390/cancers13122980. 2021

  • Open Access.

Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.

Ibáñez-Martínez E; (...); Pemán J

Case Reports. 10.1016/j.riam.2021.06.002. 2021


Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker subanalysis.

Palaz N-Carri N, Natalia; (...); de la Cruz-Merino, Luis

Article. 10.1158/1078-0432.CCR-22-0588. 2022

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

  • Open Access.

MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Tarazon, Estefania; (...); Botella Estrada, Rafael

Article. 10.3390/genes12121931. 2021

  • Open Access.

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.

Conde E; (...); de Álava E

Article. 10.1136/jclinpath-2021-207490. 2021

  • Open Access.

Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)

Franco, F; (...); Provencio, M

Article. 10.3390/curroncol28020118. 2021

  • Open Access.

NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial

Olivares-Gonzalez, Lorena; (...); Rodrigo, Regina

Article. 10.3389/fnut.2022.847910. 2022

  • Open Access.

Pain Standards for Accredited Healthcare Organizations (ACDON Project): A Mixed Methods Study.

Perez, Concepcion; (...); Mira, Jose J.

Article. 10.3390/jpm11020102. 2021

  • Open Access.

Patient benefit as a goal of humanization

David Gil-Sierra, Manuel, del Pilar Briceno-Casado, Maria, Lopez-Briz, Eduardo

Article. 10.7399/fh.13171. 2022


Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.

Pedrosa, Lucia; (...); Sanchez-Beato, Margarita

Article. 10.1038/s41598-020-80376-0. 2021

  • Open Access.

RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study

Conde, E.; (...); Lopez-Rios, F.

Meeting Abstract. 2021


RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC

Hernandez, S.; (...); Conde, E.

Meeting Abstract. 2022


Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients

Simarro, Javier; (...); Palanca, Sarai

Article. 10.3390/ijms23158526. 2022

  • Open Access.

Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report.

Simarro J; (...); Palanca S

Article. 10.3390/diagnostics12051266. 2022

  • Open Access.

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021


Campos de Estudio

Compartir